Yes, semaglutide may help with weight management in patients with MS, especially if they experience weight gain due to reduced mobility or other factors
This approach aims to reduce gastric retention and minimize aspiration risk
Perioperative risks of glucagon-like peptide-1 receptor agonists and their implications in airway management using supraglottic airway devices Chung-Sik Oh 1 , Soomin Lee 2 , Boohwi Hong 2 Received March 7, 2026 Revised April 6, 2026 Accepted April 13, 2026 Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for managing diabetes and obesity
The data acquired for the targeted analysis of the discovery cohort was imported into the Skyline software 57
Describing the active molecule identically does not make the products interchangeable compounded preparations are not FDA-approved, and formulation, supply, and presentation can vary